Medicamen Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	37.59	147.86	207.79	38.25	38.91
Cash & Short-Term Investments	436.79	37.59	147.86	207.79	38.25	38.91
Cash Growth	580.89%	-74.57%	-28.84%	443.26%	-1.69%	25.80%
Accounts Receivable	-	689	552.59	652.58	632.24	525.47
Other Receivables	-	246.2	223.43	219.83	196.18	225.22
Receivables	-	935.2	776.03	872.41	828.42	750.69
Inventory	-	621.37	593.75	450.57	270.1	52.04
Prepaid Expenses	-	1.72	1.57	0.65	7.35	4.26
Other Current Assets	-	49.62	76.73	102.21	86.26	114.43
Total Current Assets	-	1,645	1,596	1,634	1,230	960.33
Property, Plant & Equipment	-	863.62	909.52	917.59	921.18	894.35
Other Intangible Assets	-	7.42	8.98	8.98	3.6	2.04
Long-Term Deferred Tax Assets	-	28.3	25.15	18.8	4.96	-2.83
Long-Term Deferred Charges	-	414.22	393.73	195.12	88.17	75.6
Other Long-Term Assets	-	12.45	12.19	11.07	8.65	7.75
Total Assets	-	2,972	2,946	2,785	2,257	1,937
Accounts Payable	-	348.17	334.57	416.52	393.12	274.34
Accrued Expenses	-	97.48	68.45	53.3	37.81	51.37
Short-Term Debt	-	295.19	295.62	233.13	192.75	109.29
Current Portion of Long-Term Debt	-	5.21	2.94	15.26	14.47	14.86
Current Income Taxes Payable	-	33.24	40.63	37	42.64	46
Current Unearned Revenue	-	-	3.18	21.31	14.41	4.75
Other Current Liabilities	-	2.33	100.17	49.22	31.71	32.13
Total Current Liabilities	-	781.62	845.55	825.74	726.91	532.74
Long-Term Debt	-	37.34	12.56	8.7	50.74	64.05
Pension & Post-Retirement Benefits	-	17.77	14.63	13.16	10.98	9.27
Long-Term Deferred Tax Liabilities	-	-0.03	-	-	-	-
Other Long-Term Liabilities	-	4.27	2.93	3.45	3.62	2.28
Total Liabilities	-	840.98	875.67	851.03	792.24	608.34
Common Stock	-	127.15	127.15	126.51	122.17	122.17
Additional Paid-In Capital	-	1,023	1,023	978.73	677.05	677.04
Retained Earnings	-	963.08	907.67	825.38	687.82	551.07
Comprehensive Income & Other	-	5.21	-7.01	-12.14	-22.34	-21.39
Total Common Equity	2,754	2,119	2,051	1,918	1,465	1,329
Minority Interest	-	11.98	18.92	15.66	-	-
Shareholders' Equity	2,754	2,131	2,070	1,934	1,465	1,329
Total Liabilities & Equity	-	2,972	2,946	2,785	2,257	1,937
Total Debt	386.49	337.74	311.12	257.09	257.96	188.19
Net Cash (Debt)	50.31	-300.15	-163.26	-49.3	-219.71	-149.29
Net Cash Per Share	3.79	-23.61	-12.90	-3.90	-17.98	-12.22
Filing Date Shares Outstanding	18.08	12.71	12.71	12.65	12.22	12.22
Total Common Shares Outstanding	18.08	12.71	12.71	12.65	12.22	12.22
Working Capital	-	863.88	750.38	807.89	503.47	427.59
Book Value Per Share	161.11	166.62	161.30	151.65	119.89	108.78
Tangible Book Value	2,748	2,111	2,042	1,910	1,461	1,327
Tangible Book Value Per Share	160.72	166.04	160.60	150.94	119.60	108.61
Land	-	9.42	9.42	9.42	9.42	9.42
Buildings	-	374.91	373.19	371.88	370.28	341.95
Machinery	-	985.95	966.94	907.24	853.66	798.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.